Cargando…

FTY720, a sphingosine analog, altered placentome histoarchitecture in ewes

BACKGROUND: The lysosphingolipid, sphingosine-1-phosphate, is a well-described and potent pro-angiogenic factor. Receptors, as well as the sphingosine phosphorylating enzyme sphingosine kinase 1, are expressed in the placentomes of sheep and the decidua of rodents; however, a function for this signa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunlap, Kathrin A., White, Bryan G., Erikson, David W., Satterfield, M. Carey, Pfarrer, Christiane, Wu, Guoyao, Bazer, Fuller W., Burghardt, Robert C., Bayless, Kayla J., Johnson, Greg A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943922/ https://www.ncbi.nlm.nih.gov/pubmed/31911836 http://dx.doi.org/10.1186/s40104-019-0411-0

Ejemplares similares

Development of a surgical procedure for removal of a placentome from a pregnant ewe during gestation
por: Lambo, Colleen A., et al.
Publicado: (2020)

FTY720-derivatives do not induce FTY720-like lymphopenia
por: Segura-Ulate, Ismael, et al.
Publicado: (2017)

The effect of the sphingosine‐1‐phosphate analogue FTY720 on atrioventricular nodal tissue
por: Egom, Emmanuel E., et al.
Publicado: (2015)

FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons
por: Takasugi, Nobumasa, et al.
Publicado: (2013)

The emerging role of FTY720 as a sphingosine 1‐phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms
por: Naseh, Maryam, et al.
Publicado: (2021)

Sphingosine Kinase 2 Phosphorylation of FTY720 is Unnecessary for Prevention of Light-Induced Retinal Damage
por: Qi, Hui, et al.
Publicado: (2019)

Magnetic resonance imaging of placentome development in the pregnant Ewe
por: Flouri, Dimitra, et al.
Publicado: (2021)

FTY720 attenuates excitotoxicity and neuroinflammation
por: Cipriani, Raffaela, et al.
Publicado: (2015)

Uterine biology in pigs and sheep
por: Bazer, Fuller W, et al.
Publicado: (2012)

FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells
por: Tonelli, Francesca, et al.
Publicado: (2010)

Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model
por: Moon, Myung-Hee, et al.
Publicado: (2012)

Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers
por: Camp, Sara M., et al.
Publicado: (2020)

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
por: Alshaker, Heba, et al.
Publicado: (2017)

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation
por: Ahmed, Naseer, et al.
Publicado: (2017)

The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod
por: Patmanathan, Sathya Narayanan, et al.
Publicado: (2015)

The emerging role of FTY720 (Fingolimod) in cancer treatment
por: White, Christopher, et al.
Publicado: (2016)

Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy
por: Enoru, Julius O., et al.
Publicado: (2016)

Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosis
por: Pinki,, et al.
Publicado: (2011)

Antinociceptive activity of the S1P-receptor agonist FTY720
por: Coste, Ovidiu, et al.
Publicado: (2008)

FTY720 Story. Its Discovery and the Following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology
por: Adachi, Kunitomo, et al.
Publicado: (2007)

Cardioprotective Effects of Sphingosine-1-Phosphate Receptor Immunomodulator FTY720 in a Clinically Relevant Model of Cardioplegic Arrest and Cardiopulmonary Bypass
por: Ahmed, Naseer, et al.
Publicado: (2019)

FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages
por: Tachibana, Koki, et al.
Publicado: (2022)

Analogs of FTY720 inhibit TRPM7 but not S1PRs and exert multimodal anti-inflammatory effects
por: Busey, Gregory W., et al.
Publicado: (2023)

Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation
por: Shrestha, Jitendra, et al.
Publicado: (2018)

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
por: Sharma, Sushil, et al.
Publicado: (2011)

Lymphocyte Modulation with FTY720 Improves Hemorrhagic Shock Survival in Swine
por: Hawksworth, Jason S., et al.
Publicado: (2012)

FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value
por: Thomson, Andrew
Publicado: (2006)

The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
por: Stradner, Martin H, et al.
Publicado: (2011)

FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination
por: Blanc, Caroline A, et al.
Publicado: (2014)

Development and Effects of FTY720 Ophthalmic Solution on Corneal Allograft Survival
por: Liu, Zhaochuan, et al.
Publicado: (2015)

Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage
por: Xu, Hao-Liang, et al.
Publicado: (2015)

FTY720 restores endothelial cell permeability induced by malaria sera
por: Oggungwan, Karanyaporn, et al.
Publicado: (2018)

FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways
por: Lange, Ingo, et al.
Publicado: (2017)

Effect of FTY720P on lipid accumulation in HEPG2 cells
por: Rida, Reem, et al.
Publicado: (2023)

FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning
por: Vessey, Donald A., et al.
Publicado: (2013)

A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models
por: Vidal-Martinez, Guadalupe, et al.
Publicado: (2020)

S1P(1) receptor phosphorylation, internalization, and interaction with Rab proteins: effects of sphingosine 1-phosphate, FTY720-P, phorbol esters, and paroxetine
por: Martínez-Morales, Juan Carlos, et al.
Publicado: (2018)

Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720
por: Roggeri, Alessandra, et al.
Publicado: (2023)

Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
por: Wu, Celina, et al.
Publicado: (2013)

Fingolimod (FTY720) Stimulates Ca(2+)/Calcineurin Signaling in Fission Yeast
por: Hagihara, Kanako, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4jr3uagc33gmi2hqv9vp396477